Enzyme replacement therapy in porphyrias. V. In vivo correction of δ-aminolaevulinate dehydratase defective in erythrocytes in lead intoxicated animals by enzyme-loaded red blood cell ghosts

Resealed erythrocyte ghosts are potential in vivo carriers of exogenous therapeutic enzymes. In the present work, the effect of administering δ-aminolaevulinate dehydratase (ALA-D) encapsulated in autologous red blood cell ghosts (RBCg) to lead intoxicated and normal mice was investigated. Administr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado: 1989
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_08842884_v5_n2_p125_Bustos
http://hdl.handle.net/20.500.12110/paper_08842884_v5_n2_p125_Bustos
Aporte de:
id paper:paper_08842884_v5_n2_p125_Bustos
record_format dspace
spelling paper:paper_08842884_v5_n2_p125_Bustos2023-06-08T15:46:33Z Enzyme replacement therapy in porphyrias. V. In vivo correction of δ-aminolaevulinate dehydratase defective in erythrocytes in lead intoxicated animals by enzyme-loaded red blood cell ghosts Aminolevulic acid dehydratase Enzyme replacement therapy Lead intoxication Porphyrias Red blood cell ghosts porphobilinogen synthase animal experiment animal model article autologous blood bioavailability blood level congenital disorder erythrocyte ghost head intoxication intravenous drug administration kidney liver mouse nonhuman porphyria priority journal spleen Animal Erythrocyte Membrane Erythrocytes Female Lead Poisoning Mice Mice, Inbred Strains Porphobilinogen Synthase Porphyria Support, Non-U.S. Gov't Resealed erythrocyte ghosts are potential in vivo carriers of exogenous therapeutic enzymes. In the present work, the effect of administering δ-aminolaevulinate dehydratase (ALA-D) encapsulated in autologous red blood cell ghosts (RBCg) to lead intoxicated and normal mice was investigated. Administration of ALA-D loaded RBCg to intoxicated mice produced an immediate and permanent recovery in erythrocytic ALA-D activity; the effect was also noticeable in liver and spleen and absent in kidney, indicating that the entrapped enzyme was significantly stabilized to allow retention of activity in both circulating and phagocytized cells. Administration of ALA-D loaded ghosts to normal mice did not produce significant changes in ALA-D activity in blood, liver, spleen or kidney. Administration of free exogenous enzyme or blood transfusion during lead intoxication was also ineffective; spontaneous recovery of the poisoned animals was very slow. We show that circulating as well as phagocytized ALA-D entrapped in autologous erythrocyte ghosts can be safe and beneficial in the treatment of lead poisoning. Clinical trial in patients is recommended. 1989 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_08842884_v5_n2_p125_Bustos http://hdl.handle.net/20.500.12110/paper_08842884_v5_n2_p125_Bustos
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Aminolevulic acid dehydratase
Enzyme replacement therapy
Lead intoxication
Porphyrias
Red blood cell ghosts
porphobilinogen synthase
animal experiment
animal model
article
autologous blood
bioavailability
blood level
congenital disorder
erythrocyte ghost
head
intoxication
intravenous drug administration
kidney
liver
mouse
nonhuman
porphyria
priority journal
spleen
Animal
Erythrocyte Membrane
Erythrocytes
Female
Lead Poisoning
Mice
Mice, Inbred Strains
Porphobilinogen Synthase
Porphyria
Support, Non-U.S. Gov't
spellingShingle Aminolevulic acid dehydratase
Enzyme replacement therapy
Lead intoxication
Porphyrias
Red blood cell ghosts
porphobilinogen synthase
animal experiment
animal model
article
autologous blood
bioavailability
blood level
congenital disorder
erythrocyte ghost
head
intoxication
intravenous drug administration
kidney
liver
mouse
nonhuman
porphyria
priority journal
spleen
Animal
Erythrocyte Membrane
Erythrocytes
Female
Lead Poisoning
Mice
Mice, Inbred Strains
Porphobilinogen Synthase
Porphyria
Support, Non-U.S. Gov't
Enzyme replacement therapy in porphyrias. V. In vivo correction of δ-aminolaevulinate dehydratase defective in erythrocytes in lead intoxicated animals by enzyme-loaded red blood cell ghosts
topic_facet Aminolevulic acid dehydratase
Enzyme replacement therapy
Lead intoxication
Porphyrias
Red blood cell ghosts
porphobilinogen synthase
animal experiment
animal model
article
autologous blood
bioavailability
blood level
congenital disorder
erythrocyte ghost
head
intoxication
intravenous drug administration
kidney
liver
mouse
nonhuman
porphyria
priority journal
spleen
Animal
Erythrocyte Membrane
Erythrocytes
Female
Lead Poisoning
Mice
Mice, Inbred Strains
Porphobilinogen Synthase
Porphyria
Support, Non-U.S. Gov't
description Resealed erythrocyte ghosts are potential in vivo carriers of exogenous therapeutic enzymes. In the present work, the effect of administering δ-aminolaevulinate dehydratase (ALA-D) encapsulated in autologous red blood cell ghosts (RBCg) to lead intoxicated and normal mice was investigated. Administration of ALA-D loaded RBCg to intoxicated mice produced an immediate and permanent recovery in erythrocytic ALA-D activity; the effect was also noticeable in liver and spleen and absent in kidney, indicating that the entrapped enzyme was significantly stabilized to allow retention of activity in both circulating and phagocytized cells. Administration of ALA-D loaded ghosts to normal mice did not produce significant changes in ALA-D activity in blood, liver, spleen or kidney. Administration of free exogenous enzyme or blood transfusion during lead intoxication was also ineffective; spontaneous recovery of the poisoned animals was very slow. We show that circulating as well as phagocytized ALA-D entrapped in autologous erythrocyte ghosts can be safe and beneficial in the treatment of lead poisoning. Clinical trial in patients is recommended.
title Enzyme replacement therapy in porphyrias. V. In vivo correction of δ-aminolaevulinate dehydratase defective in erythrocytes in lead intoxicated animals by enzyme-loaded red blood cell ghosts
title_short Enzyme replacement therapy in porphyrias. V. In vivo correction of δ-aminolaevulinate dehydratase defective in erythrocytes in lead intoxicated animals by enzyme-loaded red blood cell ghosts
title_full Enzyme replacement therapy in porphyrias. V. In vivo correction of δ-aminolaevulinate dehydratase defective in erythrocytes in lead intoxicated animals by enzyme-loaded red blood cell ghosts
title_fullStr Enzyme replacement therapy in porphyrias. V. In vivo correction of δ-aminolaevulinate dehydratase defective in erythrocytes in lead intoxicated animals by enzyme-loaded red blood cell ghosts
title_full_unstemmed Enzyme replacement therapy in porphyrias. V. In vivo correction of δ-aminolaevulinate dehydratase defective in erythrocytes in lead intoxicated animals by enzyme-loaded red blood cell ghosts
title_sort enzyme replacement therapy in porphyrias. v. in vivo correction of δ-aminolaevulinate dehydratase defective in erythrocytes in lead intoxicated animals by enzyme-loaded red blood cell ghosts
publishDate 1989
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_08842884_v5_n2_p125_Bustos
http://hdl.handle.net/20.500.12110/paper_08842884_v5_n2_p125_Bustos
_version_ 1768545515123769344